AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

BACKGROUND: AHNAK, also known as desmoyokin, is a giant protein with the molecular size of approximately 700 kDa and exerts diverse functions in different types of cancer. RESULTS: In the present study, we demonstrated that AHNAK mRNA levels were down-regulated in 7 out of 8 human breast cancer cell...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Chen, Bo, Wang, Jin, Dai, Danian, Zhou, Qingyu, Guo, Xiaofang, Tian, Zhi, Huang, Xiaojia, Yang, Lu, Tang, Hailin, Xie, Xiaoming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5427595/
https://ncbi.nlm.nih.gov/pubmed/28494797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0522-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados